Cambridge, United Kingdom

Wyn Forrest-Owen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wyn Forrest-Owen. Retrieved from https://idiyas.com/inventor/wyn-forrest-owen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wyn Forrest-Owen: Innovator in Recombinant Polypeptide Production

Introduction

Wyn Forrest-Owen is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of cell lines for recombinant protein production. His work has implications for various applications in medicine and research.

Latest Patents

Wyn Forrest-Owen holds a patent related to a Chinese hamster ovary cell line, which is deposited with the European Collection of Cell Cultures (ECACC) under accession number 10090201. This invention encompasses the use of the cell line for the production of a recombinant polypeptide, a kit comprising the cell line, and methods for the production of recombinant polypeptide. He has 1 patent to his name.

Career Highlights

Wyn is currently employed at MedImmune Limited, where he continues to advance his research and development efforts. His work at MedImmune has positioned him as a key player in the biotechnology sector, contributing to innovative solutions in the field.

Collaborations

Wyn has collaborated with notable colleagues, including Diane Hatton and Ray Field. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Wyn Forrest-Owen's contributions to biotechnology, particularly through his patented work with Chinese hamster ovary cell lines, highlight his role as an innovator in the field. His ongoing efforts at MedImmune Limited continue to push the boundaries of recombinant polypeptide production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…